MEDREGEN LLC has a total of 14 patent applications. Its first patent ever was published in 2010. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals are LABORATORIOS LIOMONT S A DE C V, HELVACIZADE GIDA ILAC KIMYA SANAYI VE TICARET ANONIM SIRKETI and STANDARD CHEM & PHARM CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Sun Zhaoli | 14 |
#2 | Williams George Melville | 4 |
#3 | Li Xuhang | 2 |
#4 | Lin Qing | 1 |
Publication | Filing date | Title |
---|---|---|
CN108367052A | Pharmaceutical composition for treating tissue damage | |
US2016008331A1 | Methods of treating inflammatory bowel disease with amd3100 and tacrolimus | |
US2016106710A1 | Methods of recruiting SDF-producing macrophages | |
EP3808368A2 | Treatment methods utilizing stem cell mobilizers and immunosuppressive agents |